Task force co-chair Brad Finegood speaks during a briefing with King County elected officials on Sept. 15.
Task force co-chair Brad Finegood speaks during a briefing with King County elected officials on Sept. 15.

A county heroin and opioid addiction task force issued its recommendations as to how King County and Seattle officials should move ahead on dealing with drug abuse as a public health issue on Thursday, Sept. 15.

Chief among the task force’s recommendations were a recommendation to increase the supply of overdose-reversing drug naloxone, and creating two supervised injection sites in King County.

The eight recommendations also included provisions for addiction treatment and prevention, such as disposal facilities for drugs and medications, and alleviating barriers to treatment programs.

“We can prevent people from experiencing this torment in the first place,” said County Executive Dow Constantine.

The task force was formed in March by Constantine, with Seattle Mayor Ed Murray, Auburn Mayor Nancy Backus and Renton Mayor Denis Law, with the intention of bringing together experts from various fields to deliver strategies for handling an epidemic of opioid abuse.

According to studies cited in the task force’s report, prescription opiates were the leading cause of overdose deaths in King County prior to 2013. Heroin surpassed prescription opiates as the overdose killer that year. Heroin deaths hit 156 in 2014, the highest in 17 years.

A decrease in doctors prescribing prescription drugs from 2005 to 2010 indeed correlated with lower self-reported use of the same among high school students. However, 14 and 15 are now the peak ages at which heroin users report they began using.

“Living life with heroin is not easy,” said task force member Thea Oliphant-Wells.

A social worker for Public Health Seattle and King County, Oliphant-Wells struggled with ongoing heroin use until the mid-2000s. Access to harm reduction services opened the door — and her mind — to the counseling and help that let her get clean.

Oliphant-Wells specifically pointed at supervised injection sites as a potential source for help for struggling addicts.

“The remarkable thing is I got what I needed,” she said. “And that shouldn’t be remarkable.”

The task force has named these sites Community Health Engagement Locations for individuals with substance abuse disorders, or CHEL sites. 

The task force did not specify where CHEL sites might be located, other than to recommend two such sites in areas of high substance abuse — one within Seattle city limits and one outside. 

Murray said he will soon embark on a fact-finding mission in Vancouver, British Columbia, to determine how that city decided on its injection sites.

The task force also did not estimate the cost of establishing the CHEL sites.

“We don’t know the cost of any of it,” Constantine said, though he noted the opioid epidemic had already incurred great financial and human cost.

Looming large in the task force’s recommendations is a proposal to reduce barriers and increase the availability of buprenorphine, an opioid that, much like methadone, is used for the cessation of heroin or prescription drug use. Unlike methadone, buprenorphine has a so-called “ceiling effect,” in which its effects plateau and do not respond to greater dosages.

“There are few prescriptions I can write that are more powerful than buprenorphine, methadone or long-acting naloxone,” said Charissa Fotinos, a physician and the deputy chief medical officer for the Washington’s Health Care Authority and the Behavioral Health Administration of the Department of Social and Health Services. “If I prescribe a patient buprenorphine, I know I can reduce their risk of dying by 50 percent.”

County Sheriff John Urquhart applauded the potential for a shift to a focus on public health concerning the opioid epidemic.

“The war of drugs has failed,” Urquhart said. “I was a foot soldier in that war, and I saw it fail.”